Characteristics and immune checkpoint inhibitor effects on non-smoking non-small cell lung cancer with KRAS mutation: A single center cohort (STROBE-compliant)

Kirsten rat sarcoma (KRAS) mutation (KRASm) is associated with poor prognosis in non-small cell lung cancer (NSCLC) patients. We have aimed to survey NSCLC patients harboring KRASm in Taiwan, where never-smoking lung adenocarcinoma predominates, and analyze the immune checkpoint inhibitor effect on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jia-Jun, Lee, Po-Hsin, Zheng, Zhe-Rong, Huang, Yen-Hsiang, Tseng, Jeng-Sen, Hsu, Kuo-Hsuan, Yang, Tsung-Ying, Yu, Sung-Liang, Chen, Kun-Chieh, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276274/
https://www.ncbi.nlm.nih.gov/pubmed/35713442
http://dx.doi.org/10.1097/MD.0000000000029381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276274/
https://www.ncbi.nlm.nih.gov/pubmed/35713442
http://dx.doi.org/10.1097/MD.0000000000029381

Ejemplares similares